Free Trial

Chinese Stocks To Follow Now - October 23rd

Diageo logo with Consumer Staples background

Key Points

  • Diageo, UP Fintech, and Regencell Bioscience are highlighted as notable Chinese stocks to monitor due to their high trading volumes recently.
  • UP Fintech specializes in providing online brokerage services to Chinese investors, offering a platform for trading various financial instruments.
  • Regencell Bioscience is focused on Traditional Chinese Medicine (TCM) for treating neurocognitive disorders like ADHD and autism spectrum disorder.
  • Five stocks to consider instead of Diageo.

Diageo, UP Fintech, and Regencell Bioscience are the three Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity shares of companies that are based in or derive the bulk of their revenue from the People's Republic of China, and they can be traded on domestic exchanges (Shanghai, Shenzhen), the Hong Kong Stock Exchange, or internationally via foreign listings and American Depositary Receipts (ADRs). For investors the term encompasses A-shares, H-shares, offshore-listed Chinese firms (often incorporated in places like the Cayman Islands), and other China-focused securities, each subject to different regulatory, currency, and access considerations. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

Further Reading

Should You Invest $1,000 in Diageo Right Now?

Before you consider Diageo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diageo wasn't on the list.

While Diageo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.